News

EU officials are contemplating switching the formula for funding large-scale, multidisciplinary projects, replacing broad-brush flagships with targeted missions. Why spend €1B on brain research, if you could invest the money in a cure for Alzheimer’s? asks Research Commissioner Carlos Moedas  

President of R&D at GlaxoSmithKline, Patrick Vallance, will replace Mark Walport in April 2018

The Commission awards €1M European Capital of Innovation prize to Paris

Researchers studying neurodegenerative disease can now look up cohort studies and make connections through an online database.

The EU wants scientists to find out exactly how environmental factors, including lifestyle and climate change, drive the development of non-communicable disease

The genomics revolution has brought personalised medicine to cancer and rare diseases, but cardiovascular care is stuck in the past. An EU-funded initiative aims to change that

The Paediatric Regulation has “basically forced” companies to tailor drugs for use by children, but more work is needed to plug gaps in the area of childhood rare diseases

The WannaCry hack was relatively unsophisticated and could have been prevented with basic IT security best practice. There are greater cyber threats out there and the NHS must ensure it is better protected